Effects of BI 425809 in schizophrenia patients
To evaluate efficacy of BI 425809 (a glycine transporter inhibitor) on cognitive functioning in patients with schizophrenia.
Sanne Brederoo, Pernell Willemsen, Priscilla Oomen, prof. dr. Iris Sommer
Patients with schizophrenia, aged 18-50 years, with cognitive deficits.